Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
CLSA Premium Ltd. ( (HK:6877) ) has issued an update.
Top Eminent Healthcare Group Limited has updated the terms of reference for its corporate governance committee, reflecting revisions first adopted in 2012 and amended in 2017. The latest changes, reviewed by the committee on 13 March 2026 and approved by the board on 16 March 2026, incorporate 2025 Corporate Governance Code updates on ESG reporting and board diversity.
Under the revised framework, the committee must comprise at least three directors with a majority of independent non-executive members, and its chair is appointed by the board. The document also formalizes meeting procedures, quorum requirements, and the role of the company secretary, reinforcing the company’s governance structure and alignment with evolving Hong Kong listing and ESG standards.
The most recent analyst rating on (HK:6877) stock is a Hold with a HK$0.15 price target. To see the full list of analyst forecasts on CLSA Premium Ltd. stock, see the HK:6877 Stock Forecast page.
More about CLSA Premium Ltd.
Top Eminent Healthcare Group Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating in the healthcare sector. The group is overseen by a board of directors and maintains board-level committees to manage corporate governance and regulatory compliance across its operations.
Average Trading Volume: 943,061
Technical Sentiment Signal: Sell
Current Market Cap: HK$335.5M
See more data about 6877 stock on TipRanks’ Stock Analysis page.